EXELIXIS, INC.·4

May 15, 7:44 PM ET

WYSZOMIERSKI JACK L 4

4 · EXELIXIS, INC. · Filed May 15, 2024

Insider Transaction Report

Form 4
Period: 2024-05-13
Transactions
  • Sale

    Common Stock

    2024-05-13$21.37/sh10,923$233,425338,948 total
  • Exercise/Conversion

    Common Stock

    2024-05-13$19.57/sh+11,686$228,695349,871 total
  • Exercise/Conversion

    Option (right to buy)

    2024-05-1311,6860 total
    Exercise: $19.57From: 2017-05-25Exp: 2024-05-24Common Stock (11,686 underlying)
Footnotes (4)
  • [F1]Includes 20,718 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
  • [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2024.
  • [F3]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.30 to $21.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
  • [F4]The option, representing the right to purchase a total of 11,686 shares of Exelixis, Inc. common stock, became fully exercisable on May 25, 2017.

Documents

1 file
  • 4
    wk-form4_1715816662.xmlPrimary

    FORM 4